EUVIMEDEUVIMED entdecken
Crossref

Ferritin and Encapsulin Nanoparticles Enhance Immunogenicity of p30 Protein for ASFV Vaccine Development

Yue Zhang iD, Longhe Zhao, Rongzeng Hao, Yang Yang, Chaochao Shen, Zhengwang Shi, Yi Ru, Haixue Zheng

ACS Biomaterials Science & Engineering · 14.07.2025 · 11 (7) · 4193-4205

DOI: 10.1021/acsbiomaterials.5c00050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 27.06.2025. Verfasst von Yue Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Insti…. Hauptthemen laut MEDLINE: Nanoparticles, African Swine Fever Virus, Ferritins, Vaccine Development. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Agricultural Sciences, Government of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

African swine fever (ASF) represents a significant threat to the global swine industry due to the absence of a commercially available vaccine. The rational design of vaccine antigens is crucial for improving vaccine efficacy and guiding its development. The p30 protein of the African swine fever virus (ASFV) is an early membrane protein involved in the viral invasion of host cells. Antibodies against p30 effectively block viral internalization, highlighting its potential as a key vaccine antigen. In this study, ferritin and encapsulin nanoparticle platforms were utilized to display the p30 protein on their surfaces. The F/E-p30 nanoparticles significantly enhanced both the antigenicity and immunogenicity of the p30 protein. In vivo experiments revealed that the p30 protein, conjugated onto nanoparticles, accumulated in follicular dendritic cells (FDCs) within lymph nodes. This accumulation resulted in an increased number of T follicular helper (Tfh) and germinal center B (GCB) cells, thereby promoting the activation and maturation of both B and T cells. Compared to the p30 monomer, the p30 nanoparticles elicited stronger immune responses and facilitated the production of more potent, broad-spectrum antibodies that more effectively inhibit the internalization of genotype II and I/II recombinant ASFV strains. The p30-conjugated nanoparticles developed in this study present a competitive advantage as nanoparticle antigens, providing a robust foundation for ASFV vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAfrican Swine Fever VirusFerritinsVaccine DevelopmentViral VaccinesAfrican Swine FeverAnimalsSwineMice

Stichwörter der Autor:innen

African swine fever virusimmunogenicitynanoparticle antigensnanoparticlesp30 protein

Substanzen

FerritinsViral Vaccines

Autor:innen und Institutionen

  • State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
  • African Swine Fever Regional Laboratory of China, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
  • Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China.

ORCID-Profile: Yue Zhang

Förderung

  • National Key Research and Development Program of China
  • Chinese Academy of Agricultural Sciences
  • Government of Guangdong Province
  • Fundamental Research Funds for the Central Universities
  • Earmarked Fund for China Agriculture Research System
  • Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
  • Key Project for Science and Technology Research of Gansu Province
  • Major Science and Technology Project of Gansu Province

Zitieren

APA

Zhang, Y., Zhao, L., Hao, R., Yang, Y., Shen, C., Shi, Z., Ru, Y., & Zheng, H. (2025). Ferritin and Encapsulin Nanoparticles Enhance Immunogenicity of p30 Protein for ASFV Vaccine Development. ACS Biomaterials Science & Engineering, 11(7), 4193-4205. https://doi.org/10.1021/acsbiomaterials.5c00050

Vancouver

Zhang Y, Zhao L, Hao R, Yang Y, Shen C, Shi Z, et al. Ferritin and Encapsulin Nanoparticles Enhance Immunogenicity of p30 Protein for ASFV Vaccine Development. ACS Biomaterials Science & Engineering. 2025;11(7):4193-4205. doi:10.1021/acsbiomaterials.5c00050

BibTeX
@article{Zhang2025,
  author = {Zhang, Yue and Zhao, Longhe and Hao, Rongzeng and Yang, Yang and Shen, Chaochao and Shi, Zhengwang and Ru, Yi and Zheng, Haixue},
  title = {Ferritin and Encapsulin Nanoparticles Enhance Immunogenicity of p30 Protein for ASFV Vaccine Development},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2025},
  volume = {11},
  number = {7},
  pages = {4193--4205},
  doi = {10.1021/acsbiomaterials.5c00050}
}
Kostenlos starten →